Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Immunity|January 6, 2022
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Julian Potthoff, Sven Bizu, et al.
The Lancet Regional Health. Europe|May 24, 2021
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort studyMax Augustin, Philipp Schommers, Melanie Stecher, et al.
Cell Host & Microbe|January 1, 2022
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizersKanika Vanshylla, Chengcheng Fan, Marie Wunsch, et al.
Cell|July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Immunity|November 15, 2023
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and PentamerMatthias Zehner, Mira Alt, Artem Ashurov, et al.
Immunity|January 31, 2026
Pre-existing neutralizing antibodies against cattle-transmitted influenza A virus H5N1 are detectable in unexposed individualsKatharina Daniel, Leon Ullrich, Denis Ruchnewitz, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapyLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature Immunology|October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapyLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Pageof 32